000			02192 a2200541 4500
005			20250513044746.0
264		0	_c19950223
008			199502s 0 0 eng d
022			_a0923-7534
024	7		_a10.1093/oxfordjournals.annonc.a058975 _2doi
040			_aNLM _beng _cNLM
100	1		_aO'Shaughnessy, J A
245	0	0	_aA dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cOct 1994
300			_a709-16 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aDyspnea _xetiology
650	0	4	_aEscherichia coli
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aGranulocyte-Macrophage Colony-Stimulating Factor _xadverse effects
650	0	4	_aHumans
650	0	4	_aHypotension _xetiology
650	0	4	_aLeucovorin _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aNeutropenia _xchemically induced
650	0	4	_aRecombinant Proteins _xadverse effects
650	0	4	_aRegression Analysis
650	0	4	_aRemission Induction
650	0	4	_aSurvival Rate
700	1		_aDenicoff, A M
700	1		_aVenzon, D J
700	1		_aDanforth, D
700	1		_aPierce, L J
700	1		_aFrame, J N
700	1		_aBastian, A
700	1		_aGhosh, B
700	1		_aGoldspiel, B
700	1		_aMiller, L
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 5 _gno. 8 _gp. 709-16
856	4	0	_uhttps://doi.org/10.1093/oxfordjournals.annonc.a058975 _zAvailable from publisher's website
999			_c7826247 _d7826247